Holtgrave D R, Kelly J A
Department of Psychiatry and Behavioral Medicine, Medical College of Wisconsin, Milwaukee 53202, USA.
Am J Public Health. 1996 Oct;86(10):1442-5. doi: 10.2105/ajph.86.10.1442.
A human immunodeficiency virus (HIV) intervention trial for women at high risk for acquired immunodeficiency syndrome and attending an urban clinic was reported previously. The behavioral group intervention was shown to increase condom use behaviors significantly. This study retrospectively assessed the intervention's cost-effectiveness.
Standard methods of cost and cost-utility analysis were used.
The intervention cost was just over $2000 for each quality-adjusted life-year saved; this is favorable compared with other life-saving programs. However, the results are sensitive to changes in some model assumptions.
Under most scenarios, the HIV prevention intervention was cost-effective.
先前报道了一项针对获得性免疫缺陷综合征高危女性且在城市诊所就诊的人类免疫缺陷病毒(HIV)干预试验。行为组干预措施被证明能显著增加安全套使用行为。本研究回顾性评估了该干预措施的成本效益。
采用成本和成本效用分析的标准方法。
每挽救一个质量调整生命年的干预成本略高于2000美元;与其他挽救生命的项目相比,这是有利的。然而,结果对某些模型假设的变化很敏感。
在大多数情况下,HIV预防干预措施具有成本效益。